Insulin pump therapy, or continuous subcutaneous insulin infusion (CSII), has been used in the treatment of diabetes for decades. Devices have evolved with technological advancements; some insulin pumps now feature Bluetooth connectivity and complementary smartphone applications while the use of AI technology is slowly being integrated. Modern insulin pumps are both more patient and physician-friendly as they allow for precise insulin control in diabetic patients. As a result, the number of pump users has increased manifold now totaling an estimated 350,000 patients within the United States.
The connection between obesity and type 2 diabetes is well known, leading health professionals to believe a rise in incidence of the former would positively correlate with the number of diabetes diagnoses. However, despite climbing obesity rates, the number of new cases of diabetes in U.S. adults continues to decline – a paradox confusing health officials. According to new federal data released in May of this year, 1.3 million new diabetes diagnoses were made in 2017, compared to 1.7 million in 2009.